Metlife Inc (MET) Beta Value: Understanding the Market Risk
The price-to-earnings ratio for Metlife Inc (NYSE: MET) is above average at 37.96x. The 36-month beta value for MET is also noteworthy at 1.04. There
The price-to-earnings ratio for Metlife Inc (NYSE: MET) is above average at 37.96x. The 36-month beta value for MET is also noteworthy at 1.04. There
Metlife Inc (NYSE: MET) has a higher price-to-earnings ratio of 40.33x compared to its average ratio. MET has 36-month beta value of 1.03. Analysts have
Metlife Inc (NYSE: MET) has a higher price-to-earnings ratio of 40.28x compared to its average ratio, The 36-month beta value for MET is at 1.04.
The stock of Metlife Inc (NYSE: MET) has decreased by -0.05 when compared to last closing price of 73.10.Despite this, the company has seen a
The stock price of Metlife Inc (NYSE: MET) has jumped by 0.22 compared to previous close of 72.39. Despite this, the company has seen a
© 2024, Fueled by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.